Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J4DJ
|
||||
Former ID |
DNC009480
|
||||
Drug Name |
Nocardimicin F
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C43H67N5O10
|
||||
Canonical SMILES |
CCCCCCCCCCCCCCCC(C(C)C(=O)NC1CCCCN(C1=O)O)OC(=O)C(CCCCN<br />(C(=O)C)O)NC(=O)C2=COC(=C3C=CC=CC3=O)N2
|
||||
InChI |
1S/C43H67N5O10/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-27-38(31(2)39(51)44-34-24-19-22-29-48(56)42(34)53)58-43(54)35(25-20-21-28-47(55)32(3)49)45-40(52)36-30-57-41(46-36)33-23-17-18-26-37(33)50/h17-18,23,26,30-31,34-35,38,46,55-56H,4-16,19-22,24-25,27-29H2,1-3H3,(H,44,51)(H,45,52)/b41-33+
|
||||
InChIKey |
RCRNLVZFPWYKHT-ZSJGZSGZSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M3 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Cholinergic synapse | |||||
Regulation of actin cytoskeleton | |||||
Insulin secretion | |||||
Salivary secretion | |||||
Gastric acid secretion | |||||
Pancreatic secretion | |||||
PANTHER Pathway | Alzheimer disease-amyloid secretase pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
Reactome | Muscarinic acetylcholine receptors | ||||
Acetylcholine regulates insulin secretion | |||||
G alpha (q) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
Regulation of Actin Cytoskeleton | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Integration of energy metabolism | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | J Nat Prod. 2005 Jul;68(7):1061-5.Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.